ACS is a blocking or narrowing of the carotid artery in the neck from which there have been no symptoms such as transient ischemic attacks (TIAs). The research is published in the August 17 online issue of Neurology, the medical journal of the American Academy of Neurology.
In the three-year study of ACS patients, Dr. Spence found that if three or more ulcers were found in the carotid arteries using 3D ultrasound, the patient was at high risk of stroke and could benefit from intervention. He compared it to the proven transcranial Doppler which detects pieces of plaque called microemboli breaking off and entering the blood stream, and found both identified those ACS patients most at risk of having a stroke.
Surgical interventions such as stenting where a stent is threaded from an artery in the groin up to the narrowed carotid artery and then deployed, and carotid endarterectomy, where the blocked artery is opened and the plaque cleaned out, both carry their own risks and costs. Dr. Spence showed in earlier studies (2005) that 90 per cent of patients with ACS were better off being treated with medical therapy. With more intensive medical therapy, the proportion who could benefit from intervention had declined by 2010 to less than five per cent.
“Now we’ve developed two ways to identify the few who could benefit from surgery or stenting,” says Dr. Spence, a Professor in the Department of Clinical Neurological Sciences at Western’s Schulich School of Medicine & Dentistry and a scientist in its Robarts Research Institute. “The reason it’s important is that in the United States 90 to 95 per cent of carotid endarterectomy and stenting are being done for asymptomatic carotid stenosis even though it’s not warranted for the vast majority of them. I hope this study would influence those decisions.”
The study was funded by the Heart and Stroke Foundation of Canada. “Thanks to this effort, we are that much closer to providing ways to improve system care for stroke patients,” says Manuel Arango, Director, Health Policy, Heart and Stroke Foundation of Canada.
Dr. Spence is also the Director of the Stroke Prevention & Atherosclerosis Research Centre (SPARC) at University Hospital, London Health Sciences Centre. The 3-D ultrasound imaging technology was developed at Robarts Research Institute by Dr. Aaron Fenster and his colleagues.
Media contact: Kathy Wallis, Media Relations Officer, Schulich School of Medicine & Dentistry, The University of Western Ontario, 519 661-2111 ext. 81136, cell: 519-777-1573, Kathy.email@example.com.